Advertisement

Late-onset bipolar disorder

  • John L. Beyer
  • K. Ranga R. Krishnan
Part of the Milestones in Drug Therapy book series (MDT)

Abstract

Much is still unknown about late-life bipolar disorder (BPD), especially late-onset BPD. Lateonset BPD may be etiologically different from early-onset BPD, and may be related to the medical and neurological problems that can occur with aging; alternately, it may be an underlying progression of neurological illness associated with certain cases of BPD early in life.

Treatment of late-life BPD requires knowledge of ‘best treatment’ practices and an understanding of the effect aging has on psychopharmacotherapy. This chapter discusses the various treatment options available to this population. These include the mood stabilizers (e.g., lithium) and anticonvulsants (e.g., valproate, lamotrigine) most often used to treat BPD, as well as alternative treatments such as atypical antipsychotics and ECT. However, adequate clinical trials that would provide good evidence-based treatment recommendations for late-life BPD are not currently available. Therefore, extrapolation from trials in mixed-age populations and adaptation to the older patient is necessary to establish treatment recommendations.

Keywords

Bipolar Disorder Atypical Antipsychotic Clin Psychiatry Mood Stabilizer Late Life 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    American Psychiatric Association (2000) Diagnostic and statistical manual of mental disorders, Fourth Edition: Text Revision (DSM-IV-TR). American Psychiatric Association, Washington, DCGoogle Scholar
  2. 2.
    Suppes T, Dennehy EB, Hirschfeld RM, Altshuler LL, Bowden CL, Calabrese JR, Crismon ML, Ketter TA, Sachs GS, Swann AC; Texas Consensus Conference Panel on Medication Treatment of Bipolar Disorder (2005) The Texas implementation of medication algorithms: update to the algorithms for treatment of bipolar I disorder. J Clin Psychiatry 66(7): 870–886PubMedGoogle Scholar
  3. 3.
    Goodwin GM, for the Consensus Group of the British Association for Psychopharmacology (2003) Evidence-based guidelines for treating bipolar disorder: recommendations from the British Association for Psychopharmacology. J Psychopharmacol 17: 149–173PubMedGoogle Scholar
  4. 4.
    Goodwin GM, Nolen WA (2001) Treatment of bipolar depressive mood disorders: algorithms for pharmacotherapy. Int J Psychiatr Clin Practice 1: 9–12Google Scholar
  5. 5.
    Sachs GS, Printz DJ, Kahn DA, Carpenter D, Docherty JP (2000) The expert consensus guideline series: medication treatment of bipolar disorder 2000. Postgrad Med Spec No: 1–104Google Scholar
  6. 6.
    American Psychiatric Association Committee on Nomenclature and Statistics (1952) Mental disorders: diagnostic and statistical manual. The Association, Washington, D.Google Scholar
  7. 7.
    Depp CA, Jeste DV (2004) Bipolar disorder in older adults: a critical review. Bipol Disord 6: 343–367Google Scholar
  8. 8.
    Ettner S, Hermann R (1998) Inpatient psychiatric treatment of elderly Medicare beneficiaries. Psychiatr Serv 49: 1173–1179PubMedGoogle Scholar
  9. 9.
    Weissman MM, Leaf PJ, Tischler GL, Blazer DG, Karno M, Bruce ML, Florio LP (1988) Affective disorders in five United States communities. Psychol Med 18(1): 141–153Google Scholar
  10. 10.
    Unutzer J, Simon G, Pabiniak C, Bond K, Katon W (1998) The treated prevalence of bipolar disorder in a large staff-model HMO. Psychiatr Serv 49(8): 1072–1078PubMedGoogle Scholar
  11. 11.
    Klap R, Unroe KT, Unutzer J (2003) Caring for mental illness in the United States: a focus on older adults. Am J Geriatr Psychiatry 11(5): 517–524PubMedGoogle Scholar
  12. 12.
    Hirschfeld RM, Lewis L, Vornik LA (2003) Perceptions and impact of bipolar disorder: how far have we really come? Results of the national depressive and manic-depressive association 2000 survey of individuals with bipolar disorder. J Clin Psychiatry 64(2): 161–174Google Scholar
  13. 13.
    Angst J, Baastrup P, Grof P, Hippius H, Poldinger W, Weis P (1973) The course of monopolar depression and bipolar psychoses. Psychiat Neurol Neurochir 76: 489–500PubMedGoogle Scholar
  14. 14.
    Winokur G (1975) The Iowa 500: Heterogeneity and course in manic-depressive illness (Bipolar). Comp Psychiatry 16(2): 125–131Google Scholar
  15. 15.
    Angst J, Preisig M. Course of a clinical cohort of unipolar, bipolar and schizoaffective patients. (1995) Results of a prospective study from 1959 to 1985. Schweiz Arch Neurol Psychiatr 146(1): 5–16PubMedGoogle Scholar
  16. 16.
    Sajatovic M, Blow FC, Ignacio RV, Kales HC (2005) New-onset bipolar disorder in later life. Am J Geriatr Psychiatry 13(4): 282–289PubMedGoogle Scholar
  17. 17.
    Petterson U (1977) Manic-depressive illness: A clinical, social and genetic study. Acta Psychiatrica Scandinavica 269: 1–93Google Scholar
  18. 18.
    Angst J (1978) The course of affective disorders. II. Typology of bipolar manic-depressive illness. Arch Psychaitr Nervenkr 226: 65–73Google Scholar
  19. 19.
    Goodwin FK, Jamison KR (1984) The natural course of manic depressive illness. In: RM Post, JC Ballenger (eds): Neurobiology of mood disorders. Williams & Wilkens, Baltimore, 20–37Google Scholar
  20. 20.
    Sibisi CDT (1990) Sex differences in the age of onset of bipolar affective illness. Br J Psychiatry 156: 842–845PubMedGoogle Scholar
  21. 21.
    Zis AP, Grof P, Goodwin FK (1979) The natural course of affective disorders: Implications for lithium prophylaxis. In: TB Cooper, S Gershon, NS Kline, M Shou (eds): Lithium: controversies and unsolved issues. Exerpta Medica, Amsterdam, 381–398Google Scholar
  22. 22.
    Spicer CC, Hare EH, Slater E (1973) Neurotic and psychotic forms of depressive illness: Evidence from age-incidence in a national sample. Br J Psychiatry 123: 535–541PubMedGoogle Scholar
  23. 23.
    Loranger A, Levine PM (1978) Age at onset of bipolar affective illness. Arch Gen Psychiatry 35: 1345–1348PubMedGoogle Scholar
  24. 24.
    Eagles JM, Whalley LJ (1985) Ageing and affective disorders: The age at first onset of affective disorders in Scotland, 1969–1978. Br J Psychiatry 147: 180–187PubMedGoogle Scholar
  25. 25.
    Ghadirian AM, Lalinec-Michaud M, Engelsmann F (1986) Early and late onset affective disorders: Clinical and family characteristics. Ann R I C P 19: 53–57Google Scholar
  26. 26.
    James NM (1977) Early and late onset bipolar affective disorder: A genetic study. Arch Gen Psychiatry 34: 715–717PubMedGoogle Scholar
  27. 27.
    Taylor MA, Abrams R (1973) Manic states: A genetic study of early and late onset affective disorders. Arch Gen Psychiatry 28: 656–658PubMedGoogle Scholar
  28. 28.
    Hopkinson G (1964) A genetic study of affective illness in patients over 50. Br J Psychiatry 110: 244–254PubMedGoogle Scholar
  29. 29.
    Mendlewicz J, Fieve RR, Rainer JD, Fleiss JL (1972) Manic-depressive illness: A comparative study of patients with and without a family history. Br J Psychiatry 120: 523–530PubMedGoogle Scholar
  30. 30.
    Baron M, Mendlewicz J, Klotz J (1981) Age-of-onset and genetic transmission in affective disorders. Acta Psychiatr Scand 64(5): 373–380PubMedGoogle Scholar
  31. 31.
    Stenstedt A (1952) A study in manic-depressive psychosis. StockholGoogle Scholar
  32. 32.
    Post F (1968) The factor of ageing in affective illness. In: A Coppen, A Walk (eds): Recent developments in affective disorders, special publication 2. Royal Medico-Psychological Association, London, 105–116Google Scholar
  33. 33.
    Snowdon J (1991) A retrospective case-note study of bipolar disorder in old age. Br J Psychiatry 158: 485–490PubMedGoogle Scholar
  34. 34.
    Depp CA, Jin H, Mohamed S, Kaskow J, Moore DJ, Jeste DV (2004) Bipolar disorder I middleaged and elderly adults: is age of onset important? J Nerv Ment Dis 192(11): 796–799PubMedGoogle Scholar
  35. 35.
    Hays JC, Krishnan KR, George LK, Blazer DG (1998) Age of first onset of bipolar disorder: demographic, family history, and psychosocial correlates. Depress Anxiety 7(2): 76–82PubMedGoogle Scholar
  36. 36.
    Tohen M, Shulman KI, Satlin A (1994) First-episode mania in late life. Am J Psychiatry 151(1): 130–132PubMedGoogle Scholar
  37. 37.
    Broadhead J, Jacoby R (1990) Mania in old age: A first prospective study. Int J Geriatr Psychiatry 5: 215–222Google Scholar
  38. 38.
    Glasser M, Rabins P (1984) Mania in the elderly. Age and Ageing 13: 210–213PubMedGoogle Scholar
  39. 39.
    Carlson GA, Davenport YB, Jamison K (1977) A comparison of outcome in adolescent-and lateronset bipolar manic depressive illness. Am J Psychiatry 134(8): 919–922PubMedGoogle Scholar
  40. 40.
    Wylie ME, Mulsant BH, Pollock BG, Sweet RA, Zubenko GS, Begley AE, Gregor M, Frank E, Reynolds CF 3rd, Kupfer DJ (1999) Age at onset in geriatric bipolar disorder. Am J Geriatr Psychiatry 7: 77–83PubMedGoogle Scholar
  41. 41.
    Almeida OP, Fenner S (2002) Bipolar disorder: similarities and differences between patients with illness onset before and after 65 years of age. Int Psychogeriatr 14(3): 311–322PubMedGoogle Scholar
  42. 42.
    Cook BL, Shukla S, Hoff AL, Aronson TA (1987) Mania with associated organic factors. Acta Psychiatr Scand 76: 674–677PubMedGoogle Scholar
  43. 43.
    Carlson GA, Bromet EJ, Sievers S (2000) Phenomenology and outcome of subjects with earlyand adultonset psychotic mania. Am J Psychiatry 157(2): 213–219PubMedGoogle Scholar
  44. 44.
    Shulman KI, Tohen M, Satlin A, Mallya G, Kalunian D (1992) Mania compared with unipolar depression in old age. Am J Psychiatry 149: 341–345PubMedGoogle Scholar
  45. 45.
    Starkstein SE, Robinson RG (1989) Affective disorders and cerebral vascular disease. Br J Psychiatry 154: 170–182PubMedGoogle Scholar
  46. 46.
    Starkstein SE, Robinson RG, Price TR (1987) Comparison of cortical and subcortical lesions in the production of post-stroke mood disorders. Brain 110: 1045–1059PubMedGoogle Scholar
  47. 47.
    Starkstein SE, Mayberg HS, Berthier ML, Fedoroff P, Price TR, Dannals RF, Wagner HN, Leiguarda R, Robinson RG (1990) Mania after brain injury: neuroradiological and metabolic findings. Ann Neurol 27(6): 652–659PubMedGoogle Scholar
  48. 48.
    Starkstein SE, Fedoroff P, Berthier ML, Robinson RG (1991) Manic-depressive and pure manic states after brain lesions. Biol Psychiatry 29(2): 149–158PubMedGoogle Scholar
  49. 49.
    Cassidy F, Carroll BJ (2002) Vascular risk factors in late onset mania. Psychol Med 32(2): 359–362PubMedGoogle Scholar
  50. 50.
    Subramaniam H, Dennis MS, Byrne EJ (2007) The role of vascular risk factors in late onset bipolar disorder. Int J Geriatr Psychiatry 22(8): 733–737PubMedGoogle Scholar
  51. 51.
    Wijeratne C, Malhi GS (2007) Vascular mania: an old concept in danger of sclerosing? A clinical overview. Acta Psychiatr Scand Suppl (434): 35–40PubMedGoogle Scholar
  52. 52.
    Steffens DC, Krishnan KR (1998) Structural neuroimaging and mood disorders: recent findings, implications for classification, and future directions. Biol Psychiatry 43(10): 705–712PubMedGoogle Scholar
  53. 53.
    Regenold WT, Thapar RK, Marano C, Gavirneni S, Kondapavaluru PV (2002) Increased prevalence of type 2 diabetes mellitus among psychiatric inpatients with bipolar I affective and schizoaffective disorders independent of psychotropic drug use. J Affect Disord 70: 19–26PubMedGoogle Scholar
  54. 54.
    Cassidy F, Ahearn E, Carroll BJ (1999) Elevated frequency of diabetes mellitus in hospitalized manic-depressive patients. Am J Psychiatry 156(9): 1417–1420PubMedGoogle Scholar
  55. 55.
    McIntyre RS, Soczynska JK, Beyer JL, Woldeyohannes HO, Law CW, Miranda A, Konarski JZ, Kennedy SH (2007) Medical comorbidity in bipolar disorder: re-prioritizing unmet needs. Curr Opin Psychiatry 20(4): 406–416PubMedGoogle Scholar
  56. 56.
    Beyer JL, Kuchibhatla M, Gersing K, Krishnan KRR (2005) Medical comorbidity in an outpatient bipolar clinical population. Neuropsychopharmacology 30(2): 401–404PubMedGoogle Scholar
  57. 57.
    Kessler RC, Rubinow DR, Holmes C, Abelson J, Zhao S (1997) The epidemiology of DSM-III-R bipolar I disorder in a general population survey. Psychol Med 27: 1079–1089PubMedGoogle Scholar
  58. 58.
    Cassidy F, Ahearn P, Carroll B (2001) Substance abuse in bipolar disorder. Bipolar Disord 3: 181–188PubMedGoogle Scholar
  59. 59.
    Sajatovic M, Popli A, Semple W (1996) Health resource utilization over a ten-year period by geriatric veterans with schizophrenia and bipolar disorder. J Geriatr Psychiatry Neurol 15: 128–133Google Scholar
  60. 60.
    Ponce H, Kunik M, Molinari V, Orengo C,Workman R, Reich L (1999) Divalproex sodium treatment in elderly male bipolar patients. J Geriatr Drug Therapy 12: 55–63Google Scholar
  61. 61.
    Depp CA, Lindamer LA, Folsom DP, Gilmer T, Hough RL, Garcia P, Jeste DV (2005) Differences in clinical features and mental health service use in bipolar disorder across the lifespan. Am J Geriatr Psychiatry 13(4): 290–298PubMedGoogle Scholar
  62. 62.
    Sajatovic M, Blow FC, Ignacio RV (2006) Psychiatric comorbidity in older adults with bipolar disorder. Int J Geriatr Psychiatry 21(6): 582–587PubMedGoogle Scholar
  63. 63.
    Molinari V, Marmion J (1995) Relationship between affective disorders and axis II diagnoses in geropsychiatric patients. J Geriatr Psychiatry Neurol 8: 61–64PubMedGoogle Scholar
  64. 64.
    Stone K (1989) Mania in the elderly. Br J Psychiatry 155: 220–224PubMedGoogle Scholar
  65. 65.
    Himmelhoch J, Neil J, May S, Fuchs C, Licata S (1980) Age, dementia, dyskinesias, and lithium response. Am J Psychiatry 137: 941–945PubMedGoogle Scholar
  66. 66.
    Dhingra U, Rabins PV (1991) Mania in the elderly: A 5-7 year follow-up. J Am Geriatr Soc 39(6): 581–583PubMedGoogle Scholar
  67. 67.
    Laursen TM, Munk-Olsen T, Nordentoft M, Mortensen PB (2007) Increased mortality among patients admitted with major psychiatric disorders: a register-based study comparing mortality in unipolar depressive disorder, bipolar affective disorder, schizoaffective disorder, and schizophrenia. J Clin Psychiatry 68(6): 899–907PubMedGoogle Scholar
  68. 68.
    Shulman K, Post F (1980) Bipolar affective disorder in old age. Br J Psychiatry 36: 26–32Google Scholar
  69. 69.
    Spar JE, Ford CV, Liston EH (1979) Bipolar affective disorder in aged patients. J Clinical Psychiatry 40: 504–507Google Scholar
  70. 70.
    Camus V, de Mendonca Lima CA, Antonioli D, Wertheimer J (1997) Rapid-cycling affective disorder in the elderly: clinical subtype or specific course of manic-depressive illness? J Geriatr Psychiatry Neurol 10(3): 105–110PubMedGoogle Scholar
  71. 71.
    Conlon P (1997) Rapid cycling mood disorder in the elderly. J Geriatr Psychiatry 10: 105–110Google Scholar
  72. 72.
    Gnam W, Flint AJ (1993) New onset rapid cycling bipolar disorder in an 87 year old woman. Can J Psychiatry 38(5): 324–326PubMedGoogle Scholar
  73. 73.
    King DJ, Salem SA, Meimary NS (1979) A 48-hour periodic manic-depressive illness presenting in late life. Br J Psychiatry 135: 190–191PubMedGoogle Scholar
  74. 74.
    Young RC, Falk JR (1989) Age, manic psychopathology and treatment response. Int J Geriatr Psychiatry 4: 73–78Google Scholar
  75. 75.
    Bartels S, Forester B, Miles K, Joyce T (2000) Mental health service use by elderly patients with bipolar disorder and unipolar major depression. Am J Geriatr Psychiatry 8: 160–166PubMedGoogle Scholar
  76. 76.
    Depp CA, Davis CE, Mittal D, Patterson TL, Jeste DV (2006) Health-related quality of life and functioning of middle-aged and elderly adults with bipolar disorder. J Clin Psychiatry 67(2): 215–221PubMedGoogle Scholar
  77. 77.
    American Psychiatric Association (2002) Practice guideline for the treatment of patients with bipolar disorder (revision). Am J Psychiatry 159(4 Suppl): 1–50Google Scholar
  78. 78.
    Lim PZ, Tunis SL, Edell WS, Jensik SE, Tohen M (2001) Medication prescribing patterns for patients with bipolar I disorder in hospital settings: adherence to published practice guidelines. Bipolar Disord 3(4): 165–173PubMedGoogle Scholar
  79. 79.
    Perlis RH (2005) The role of pharmacologic treatment guidelines for bipolar disorder. J Clin Psychiatry 66(Suppl 3): 37–47PubMedGoogle Scholar
  80. 80.
    Sachs GS (2003) Unmet clinical needs in bipolar disorder. J Clin Psychopharmacol 23(suppl 1): S2–S8PubMedGoogle Scholar
  81. 81.
    Van Gerpen MW, Johnson JE, Winstead DK (1999) Mania in the geriatric patient population: a review of the literature. Am J Geriatr Psychiatry 7(3): 188–202PubMedGoogle Scholar
  82. 82.
    Catterson ML, Preskorn SH, Martin RL (1997) Pharmacodynamic and pharmacokinetic considerations in geriatric psychopharmacology. Psychiatr Clin North Am 20(1): 205–218PubMedGoogle Scholar
  83. 83.
    Beyer JL, Burchitt B, Gersing K, Krishnan KR (2008) Patterns of pharmacotherapy and treatment response in elderly adults with bipolar disorder. Psychopharmacol Bull 41(1): 102–114PubMedGoogle Scholar
  84. 84.
    Sajatovic M (2002) Treatment of bipolar disorder in older adults. Int J Geriatr Psychiatry 17(9): 865–873PubMedGoogle Scholar
  85. 85.
    Beyer JL, Kuchibhatla M, Cassidy F, Looney C, Krishnan KRR (2003) Social support in elderly patients with bipolar disorder. Bipol Disord 5: 22–27Google Scholar
  86. 86.
    Young RC, Gyulai L, Mulsant BH, Flint A, Beyer JL, Shulman KI, Reynolds CF 3rd (2004) Pharmacotherapy of bipolar disorder in old age: review and recommendations. Am J Geriatr Psychiatry 12(4): 342–357PubMedGoogle Scholar
  87. 87.
    Mirchandani IC, Young RC (1993) Management of mania in the elderly: an update. Ann Clin Psychiatry 5(1): 67–77PubMedGoogle Scholar
  88. 88.
    Oshima A, Higuchi T (1999) Treatment guidelines for geriatric mood disorders. Psychiatry Clin Neurosci 53(Suppl 3): 26S–31SGoogle Scholar
  89. 89.
    Umapathy C, Mulsant BH, Pollock BG (2000) Bipolar disorder in the elderly. Psychiatr Ann 30: 473–480Google Scholar
  90. 90.
    Shulman KI, Rochon P, Sykora K, Anderson G, Mamdani M, Bronskill S, Tran CT (2003) Changing prescription patterns for lithium and valproic acid in old age: shifting practice without evidence. BMJ 326(7396): 960–961PubMedGoogle Scholar
  91. 91.
    van der Velde CD (1970) Effectiveness of lithium carbonate in the treatment of manic-depressive illness. Am J Psychiatry 123: 345–351Google Scholar
  92. 92.
    Schaffer CB, Garvey MJ (1984) Use of lithium in acutely manic elderly patients. Clin Gerontol 3: 58–60Google Scholar
  93. 93.
    Chen ST, Altshuler LL, Melnyk KA, Erhart SM, Miller E, Mintz J (1999) Efficacy of lithium versus valproate in the treatment of mania in the elderly: a retrospective study. J Clin Psychiatry 60: 181–185PubMedGoogle Scholar
  94. 94.
    Roose SP, Bone S, Haidorfer C, Dunner DL, Fieve RR (1979) Lithium treatment in older patients. Am J Psychiatry 136: 843–844PubMedGoogle Scholar
  95. 95.
    Prien RF, Caffey EM, Klett CJ (1972) Relationship between serum lithium level and clinical response in acute mania treated with lithium. Br J Psychiatry 120: 409–414PubMedGoogle Scholar
  96. 96.
    Young RC, Kalayam B, Tsuboyama G, Stokes P, Mattis S, Alexopoulos GS (1992) Mania: response to lithium across the age spectrum (abstract). Soc for Neuroscience 18: 669Google Scholar
  97. 97.
    DeBattista C, Schatzberg AF (1999) Current psychotropic dosing and monitoring guidelines. Primary Psychiatry 65–66Google Scholar
  98. 98.
    Tueth MJ, Murphy TK, Evans DL (1998) Special considerations: use of lithium in children, adolescents, and elderly populations. J Clin Psychiatry 59(Suppl 6): 66–73PubMedGoogle Scholar
  99. 99.
    McDonald WM (2000) Epidemiology, etiology, and treatment of geriatric mania. J Clin Psychiatry 61(Supp 13): 3–11PubMedGoogle Scholar
  100. 100.
    Sajatovic M, Madhusoodanan S, Coconcea N (2005) Managing bipolar disorder in the elderly: defining the role of the newer agents. Drugs Aging 22(1): 39–54PubMedGoogle Scholar
  101. 101.
    Sproule BA, Hardy BG, Shulman KI (2000) Differential pharmacokinetics of lithium in elderly patients. Drugs Aging 16(3): 165–177PubMedGoogle Scholar
  102. 102.
    Foster JR (1992) Use of lithium in elderly psychiatric patients: a review of the literature. Lithium 3: 77–93Google Scholar
  103. 103.
    Shulman KI, Mackenzie S, Hardy B (1987) The clinical use of lithium carbonate in old age: a review. Prog Neuropsychopharmacol Biol Psychiatry 11: 159–164PubMedGoogle Scholar
  104. 104.
    Evans DL, Byerly MJ, Greer RA (1995) Secondary mania: diagnosis and treatment. J Clin Psychiatry 56(Suppl 3): 31–37PubMedGoogle Scholar
  105. 105.
    Niedermier JA, Nasrallah HA (1998) Clinical correlates of response to valproate in geriatric inpatients. Ann Clin Psychiatry 10: 165–168PubMedGoogle Scholar
  106. 106.
    Noagiul S, Narayan M, Nelson CJ (1998) Divalproex treatment of mania in elderly patients. Am J Geriatr Psychiatry 6: 257–262Google Scholar
  107. 107.
    Kando JC, Tohen M, Castillo J, Zarate CA Jr (1996) The use of valproate in an elderly population with affective symptoms. J Clin Psychiatry 57: 238–240PubMedGoogle Scholar
  108. 108.
    Puryear LJ, Kunik ME, Workman R (1995) Tolerability of divalproex sodium in elderly psychiatric patients with mixed diagnoses. J Geriatr Psychiatry Neurol 8: 234–237PubMedGoogle Scholar
  109. 109.
    Regenold WT, Prasad M (2001) Uses of intravenous valproate in geriatric psychiatry. Am J Geriatr Psychiatry 9(3): 306–308PubMedGoogle Scholar
  110. 110.
    Panjehshahin MR, Bowman CJ, Yates MS (1991) Effect of valproic acid, its unsaturated metabolites and same structurally related fatty acids on the binding of warfarin and dansylsacrosine to human albumin. Biochem Pharmacol 41: 1227–1233PubMedGoogle Scholar
  111. 111.
    Reed RC, Dutta S (2006) Does it really matter when a blood sample for valproic acid concentration is taken following once-daily administration of divalproex-ER? Ther Drug Monit 28(3): 413–418Google Scholar
  112. 112.
    Fenn HH, Sommer BR, Ketter TA, Alldredge B (2006) Safety and tolerability of mood-stabilising anticonvulsants in the elderly. Expert Opin Drug Saf 5(3): 401–416PubMedGoogle Scholar
  113. 113.
    Bowden CL, Lawson DM, Cunningham M, Owen JR, Tracy KA (2002) The role of divalproex in the treatment of bipolar disorder. Psychiatr Ann 32(12): 742–750Google Scholar
  114. 114.
    Okuma T,Yamashita I, Takahashi R, Itoh H, Otsuki S,Watanabe S, Sarai K, Hazama H, Inanaga K (1990) Comparison of the antimanic efficacy of carbamazepine and lithium carbonate by double-blind controlled study. Pharmacopsychiatry 23: 143–150PubMedGoogle Scholar
  115. 115.
    Food and Drug Administration. Carbamazepine Prescribing Information to Include Recommendation of Genetic Test for Patients with Asian Ancestry. FDA News 12 December 2007. Accessed 17 February 2008 at http://www.fda.gov/bbs/topics/NEWS/2007/NEW01755.htmlGoogle Scholar
  116. 116.
    Battino D, Croci D, Rossini A, Messina S, Mamoli D, Perucca E (2003) Serum carbamazepine concentrations in elderly patients: a case-matched pharmacokinetic evaluation based on therapeutic drug monitoring data. Epilepsia 44(7): 923–929PubMedGoogle Scholar
  117. 117.
    Sajatovic M, Gyulai L, Calabrese JR, Thompson TR, Wilson BG, White R, Evoniuk G (2005) Maintenance treatment outcomes in older patients with bipolar I disorder. Am J Geriatr Psychiatry 13(4): 305–311PubMedGoogle Scholar
  118. 118.
    Sajatovic M, Ramsay E, Nanry K, Thompson T (2007) Lamotrigine therapy in elderly patients with epilepsy, bipolar disorder or dementia. Int J Geriatr Psychiatry 22(10): 945–950PubMedGoogle Scholar
  119. 119.
    Robillard M, Conn DK (2002) Lamotrigine use in geriatric patients with bipolar depression. Can J Psychiatry 47(8): 767–770PubMedGoogle Scholar
  120. 120.
    Posner J, Holdrich T, Crome P (1991) Comparison of lamotrigine pharmacokinetics in young and elderly healthy volunteers. J Pharm Med 1: 121–128Google Scholar
  121. 121.
    Hussein Z, Posner J (1997) Population pharmacokinetics of lamotrigine monotherapy in patients with epilepsy: retrospective analysis of routine monitoring data. Br J Clin Pharmacol 43(5): 457–465PubMedGoogle Scholar
  122. 122.
    Calabrese JR, Shelton MD, Rapport DJ, Kimmel SE (2002) Bipolar disorders and the effectiveness of novel anticonvulsants. J Clin Psychiatry 63(Suppl 3): 5–9PubMedGoogle Scholar
  123. 123.
    Aldenkamp AP, De Krom M, Reijs R (2003) Newer antiepileptic drugs and cognitive issues. Epilepsia 44(Suppl 4): 21–29PubMedGoogle Scholar
  124. 124.
    Frye MA, Altshuler LL, Bitran JA (1996) Clozapine in rapid cycling bipolar disorder. J Clin Psychopharmacol 16(1): 87–90PubMedGoogle Scholar
  125. 125.
    Pande AC, Crockatt JG, Janney CA, Werth JL, Tsaroucha G (2000) Gabapentin in bipolar disorder: a placebo-controlled trial of adjunctive therapy. Gabapentin Bipolar Disorder Study Group. Bipolar Disord 2(3 Pt 2): 249–255PubMedGoogle Scholar
  126. 126.
    Maidment ID (2001) Gabapentin treatment for bipolar disorders. Ann Pharmacother 35(10): 1264–1269PubMedGoogle Scholar
  127. 127.
    Vasudev K, Macritchie K, Geddes J, Watson S, Young A (2006) Topiramate for acute affective episodes in bipolar disorder. Cochrane Database Syst Rev (1): CD003384PubMedGoogle Scholar
  128. 128.
    Young AH, Geddes JR, Macritchie K, Rao SN, Vasudev A (2006a) Tiagabine in the maintenance treatment of bipolar disorders. Cochrane Database Syst Rev 3: CD005173PubMedGoogle Scholar
  129. 129.
    Young AH, Geddes JR, Macritchie K, Rao SN, Watson S, Vasudev A (2006b) Tiagabine in the treatment of acute affective episodes in bipolar disorder: efficacy and acceptability. Cochrane Database Syst Rev 3: CD004694PubMedGoogle Scholar
  130. 130.
    Aziz R, Lorberg B, Tampi RR (2006) Treatments for late-life bipolar disorder. Am J Geriatr Pharmacother 4(4): 347–364PubMedGoogle Scholar
  131. 131.
    Wagner KD, Kowatch RA, Emslie GJ, Findling RL, Wilens TE, McCague K, D’Souza J, Wamil A, Lehman RB, Berv D et al (2006) A double-blind, randomized, placebo-controlled trial of oxcarbazepine in the treatment of bipolar disorder in children and adolescents. Am J Psychiatry 163(7): 1179–1186PubMedGoogle Scholar
  132. 132.
    Jeste DV, Rockwell E, Harris MJ, Lohr JB, Lacro J (1999) Conventional versus newer antipsychotics in elderly patients. Am J Geriatr Psychiatry 7(1): 70–76PubMedGoogle Scholar
  133. 133.
    Popova E, Leighton C, Bernabarre A, Bernardo M, Vieta E (2007) Oxcarbazepine in the treatment of bipolar and schizoaffective disorders. Expert Rev Neurother 7(6): 617–626PubMedGoogle Scholar
  134. 134.
    Food and Drug Administration. FDA issues public health advisory for antipsychotic drugs used for treatment of behavioral disorders in elderly patients. FDA News 11 April 2005. Accessed 3 March 2008 at http://www.fda.gov/bbs/topics/ANSWERS/2005/ANS01350.htmlGoogle Scholar
  135. 135.
    American Diabetes Association; American Psychiatric Association; American Association of Clinical Endocrinologists; North American Association for the Study of Obesity (2004) Consensus development conference on antipsychotic drugs and obesity and diabetes. J Clin Psychiatry 65(2): 267–272Google Scholar
  136. 136.
    Meyer JM (2002) A retrospective comparison of weight, lipid, and glucose changes between risperidone-and olanzapine-treated inpatients: metabolic outcomes after 1 year. J Clin Psychiatry 63(5): 425–433PubMedGoogle Scholar
  137. 137.
    Alexopoulos GS, Streim J, Carpenter D, Docherty JP; Expert Consensus Panel for Using Antipsychotic Drugs in Older Patients (2004) Using antipsychotic agents in older patients. J Clin Psychiatry 65(Suppl 2): 5–99PubMedGoogle Scholar
  138. 138.
    Street J, Tollefson GD, Tohen M, Sanger TM, Clark WS (2000) Olanzapine for the psychotic conditions in the elderly. Psychatri Ann 30(3): 191–196Google Scholar
  139. 139.
    Beyer JL, Siegal A, Kennedy JS, Kaiser C, Tohen K, Berg P, Street J, Baker R, Tohen M, Tollefson G et al (2001) Olanzapine, divalproex, and placebo treatment non-head-to-head comparisons of older adult acute mania. Presented at the International Psychogeriatric Association, Nice, FranceGoogle Scholar
  140. 140.
    Madhusoodanan S, Brenner R, Alcantra A (2000) Clinical experience with quetiapine in elderly patients with psychotic disorders. J Geriatr Psychiatry Neurol 13(1): 28–32PubMedGoogle Scholar
  141. 141.
    Tariot P, Podgorski C, Blazina L, Leibovici A (1993) Mental disorders in the nursing home: another perspective. Am J Psychiatry 150: 1063–1069PubMedGoogle Scholar
  142. 142.
    Sajatovic M, Mullen J, Calabrese JR (2004) Quetiapine for the treatment of bipolar mania in older adults. Presented at the American Association of Geriatric Psychiatry, Baltimore, MDGoogle Scholar
  143. 143.
    Madhusoodanan S, Brecher M, Brenner R, Kasckow J, Kunik M, Negron AE, Pomara N (1999) Risperidone in the treatment of elderly patients with psychotic disorders. Am J Geriatr Psychiatry 7(2): 132–138PubMedGoogle Scholar
  144. 144.
    Madhusoodanan S, Brenner R, Araujo L, Abaza A (1995) Efficacy of risperidone treatment for psychoses associated with schizophrenia, schizoaffective disorder, bipolar disorder, or senile dementia in 11 geriatric patients: a case series. J Clin Psychiatry 56(11): 514–518PubMedGoogle Scholar
  145. 145.
    Shulman RW, Singh A, Shulman KI (1997) Treatment of elderly institutionalized bipolar patients with clozapine. Psychopharmacol Bull 33(1): 113–118PubMedGoogle Scholar
  146. 147.
    AC, Rice JA, Keller MB (2002) The long-term natural history of the weekly symptomatic status of bipolar I disorder. Arch Gen Psychiatry 59(6): 530–537PubMedGoogle Scholar
  147. 149.
    DA, Leon AC, Keller MB (2003) A prospective investigation of the natural history of the longterm weekly symptomatic status of bipolar II disorder. Arch Gen Psychiatry 60(3): 261–269PubMedGoogle Scholar
  148. 150.
    Thase ME (2005) Bipolar depression: issues in diagnosis and treatment. Harv Rev Psychiatry 13(5): 257–271PubMedGoogle Scholar
  149. 151.
    Ghaemi SN, Hsu DJ, Soldani F, Goodwin FK (2003) Antidepressants in bipolar disorder: the case for caution. Bipolar Disord 5(6): 421–433PubMedGoogle Scholar
  150. 152.
    Thase ME, Denko T (2008) Pharmacotherapy of mood disorders. Ann Rev Clin Psychology 4: 53–91Google Scholar
  151. 153.
    Thase ME (2007) STEP-BD and bipolar depression: what have we learned. Curr Psychiatry Rep 9: 497–503PubMedGoogle Scholar
  152. 154.
    Young RC, Jain H, Kiosses DN, Meyers BS (2003) Antidepressant-associated mania in late life. Int J Geriatr Psychiatry 18(5): 421–424PubMedGoogle Scholar
  153. 155.
    Mukherjee S, Sackeim HA, Schnur DB (1994) Electroconvulsive therapy of acute manic episodes: a review of 50 years’ experience. Am J Psychiatry 151(2): 169–176PubMedGoogle Scholar
  154. 156.
    Valenti M, Benabarre A, Garcia-Amador M, Molina O, Bernardo M, Vieta E (2008) Electroconvulsive therapy in the treatment of mixed states in bipolar disorder. Eur Psychiatry 23(1): 53–56PubMedGoogle Scholar
  155. 157.
    Wilkins KM, Ostroff R, Tampi RR (2008) Efficacy of electroconvulsive therapy in the treatment of nondepressed psychiatric illness in elderly patients: a review of the literature. J Geriatr Psychiatry Neurol 21(1): 3–11PubMedGoogle Scholar
  156. 158.
    McDonald WM, Thompson TR (2001) Treatment of mania in dementia with electroconvulsive therapy. Psychopharmacol Bull 35(2): 72–82PubMedGoogle Scholar
  157. 159.
    Little JD, Atkins MR, Munday J, Lyall G, Greene D, Chubb G, Orr M (2004) Bifrontal electroconvulsive therapy in the elderly: a 2-year retrospective. J ECT 20(3): 139–141PubMedGoogle Scholar
  158. 160.
    Tsao CI, Jain S, Gibson RH, Guedet PJ, Lehrmann JA (2004) Maintenance ECT for recurrent medication-refractory mania. J ECT 20(2): 118–119PubMedGoogle Scholar
  159. 161.
    Kujala I, Rosenvinge B, Bekkelund SI (2002) Clinical outcome and adverse effects of electroconvulsive therapy in elderly psychiatric patients. J Geriatr Psychiatry Neurol 15(2): 73–76PubMedGoogle Scholar
  160. 162.
    Charney DS, Reynolds CF 3rd, Lewis L, Lebowitz BD, Sunderland T, Alexopoulos GS, Blazer DG, Katz IR, Meyers BS, Arean PA et al (2003) Depression and Bipolar Support Alliance consensus statement on the unmet needs in diagnosis and treatment of mood disorders in late life. Arch Gen Psychiatry 60(7): 664–672PubMedGoogle Scholar

Copyright information

© Birkhäuser Verlag/Switzerland 2009

Authors and Affiliations

  • John L. Beyer
    • 1
  • K. Ranga R. Krishnan
    • 1
  1. 1.Duke University Medical CenterDurhamUSA

Personalised recommendations